Skip to content
HD
Company

Updated:

HEMAGEN DIAGNOSTICS INC

HEMAGEN DIAGNOSTICS INC is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0000892822, and its reported industry...

Overview

HEMAGEN DIAGNOSTICS INC is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0000892822, and its reported industry is In Vitro & In Vivo Diagnostic Substances. In 10-K filed on 2012-12-28, it reported annual revenue of USD 4,042,094; net income of USD -907,315; total assets of USD 2,442,744 for the fiscal period ended 2012-09-30. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

Company overview

Legal name
HEMAGEN DIAGNOSTICS INC
Classification
Company
Industry (SIC)
2835 — In Vitro & In Vivo Diagnostic Substances
Headquarters
Columbia, MD, United States
Incorporated in
DE
Fiscal year end
September 30
SEC CIK
0000892822

Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

Fiscal yearPeriod endRevenueNet incomeTotal assetsCash and equivalentsOperating cash flow
FY2012USD$4.0M-$907,315$2.4M$66,287-$358,687
FY2011USD$5.1M-$880,476$2.9M$213,611-$337,168

Recent SEC filings

FormFiledPeriodFiling
8-KFORM 8-K JANUARY 30, 2013
8-KFORM 8-K
10-KFORM 10-K
10-QHEMAGEN 10-Q
8-KFORM 8-K JULY 6, 2012
10-Q10-Q
10-Q10-Q
10-K10-K
10-Q10-Q
10-QFORM 10-Q
DEF 14ADEFINITIVE PROXY STATEMENT
10-QFORM 10-Q

Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.

Research HEMAGEN DIAGNOSTICS INC in Altss

Track this company’s investors, transactions and relationships in Altss.

Book a demo

More Company profiles

HEMAGEN DIAGNOSTICS INC | Columbia Company | Altss